Table 2.
2016 IHGC migraine GWAS P value threshold | No. of SNP effects across migraine and MDDa | Proportion of SNPs with concordant effects | Concordance test P valueb | ||
---|---|---|---|---|---|
Concordant | Discordant | Total | |||
1 | 202 | 156 | 358 | 0.5642 | 1.73 × 10−2 |
0.9 | 192 | 150 | 342 | 0.5614 | 2.65 × 10−2 |
0.8 | 178 | 140 | 318 | 0.5597 | 3.78 × 10−2 |
0.7 | 166 | 124 | 290 | 0.5724 | 1.59 × 10−2 |
0.6 | 159 | 112 | 271 | 0.5867 | 5.11 × 10−3 |
0.5 | 146 | 100 | 246 | 0.5935 | 4.03 × 10−3 |
0.4 | 126 | 85 | 211 | 0.5972 | 5.76 × 10−3 |
0.3 | 109 | 69 | 178 | 0.6124 | 3.35 × 10−3 |
0.2 | 88 | 46 | 134 | 0.6567 | 3.60 × 10−4 |
0.1 | 66 | 22 | 88 | 0.7500 | 2.88 × 10−6 |
0.05 | 34 | 12 | 46 | 0.7391 | 1.64 × 10−3 |
0.01 | 14 | 3 | 17 | 0.8235 | 1.27 × 10−2 |
aThere were a total of 358 independent SNPs (linkage disequilibrium r2 < 0.1) with results in both the 2016 IHGC Migraine GWAS and the top 10,000 SNPs (P value ≤ 1 × 10−5) in the 2016 23andMe MDD GWAS
bTwo-sided exact binomial test for concordance: where the number of successes, number of trials and probability of success is the number of concordant SNPs, total SNPs and 0.5, respectively